Should the state's pension fund be used to finance the next Medtronic?
That's the question a group of lawmakers pondered Wednesday before they passed a bill that urges the Minnesota State Board of Investment, which oversees Minnesota's $63 billion in retirement assets, to direct some of that money toward early stage start-ups.
Lawmakers, industry officials and venture capitalists have long warned that Minnesota could lose its dominance in medical technology. Although the region is home to giants such as Medtronic Inc. and St. Jude Medical Inc., local start-ups have struggled to raise money from venture capitalists, especially from local investors who are more likely to keep the companies in Minnesota.
The dearth of early-stage venture capital money comes at an especially sensitive time for the state: Minnesota's job growth, which for years outpaced the national average, is lagging in nearly every major sector. Stalwarts such as Boston Scientific Corp. and Medtronic face maturing markets; both companies have pared their workforces.
"Medtronic didn't start out as a [$13 billion] company," said Rep. Tim Mahoney, DFL-St. Paul, chairman of the House Biosciences and Emerging Technologies Committee. "We got a hole in our system and we are trying to fix it."
There's widespread investor enthusiasm in the state for medical technology.
But local firms last year captured 6.4 percent of national venture-capital money in that industry, slightly down from 2006, according to the MoneyTree Report by PricewaterhouseCoopers and the National Venture Capital Association, based on data from Thomson Financial.
States such as Indiana, Texas, California, New York and Washington in recent years have directed public money, including retirement funds, into local start-ups.